Down-regulated expression of CC chemokine receptor 3 ligands in ranibizumab treated light-injured human retinal pigment epithelium cells

潘颖喆,邢怡桥,陈长征,黎智,王慧,李璐,苏钰
DOI: https://doi.org/10.3760/cma.j.issn.1005-1015.2015.01.016
2015-01-01
Abstract:Objective To observe the changes of eotaxin-1(CCL11),eotaxin-2(CCL24)and eotaxin-3 (CCL26)in ranibizumab treated light-injured human retinal pigment epithelium (RPE) cells ARPE-19 and investigate the effects of vascular endothelial growth factor (VEGF) antagonist to the expressions of eotaxins.Methods Cultured human RPE cells (8th-12th generations)were divided into light-injured group,ranibizumab treated group and normal control group.Cells of the three groups were exposed to the blue light at the intensity of(600± 100) Lux for 12 h to establish the light injured model,while cell culture dishes of the normal control group were wrapped with double-layer foil.The cells of ranibizumab treated group were treated with VEGF-A antagonist(ranibizumab)at the final concentration of 0.125 mg/ml for 24 hours directly after the illumination.The mRNA and protein of VEGF-A,eotaxin-1,eotaxin-2,eotaxin-3,NF-κB were determined by Real time-PCR,enzyme-linked immunosorbent assay,Western blot,immunohistochemical staining at 0,3,6,12,24 hours after light damage.Results The mRNA and protein level of VEGF-A,eotaxin-1,eotaxin-2,eotaxin-3,NF-κB in the light-injuried group increased significantly compared to that in normal control group (P<0.05).After treating with ranibizumab,the expression of eotaxin-1,eotaxin-2,eotaxin-3,NF-κB were significantly suppressed (P < 0.05).Conclusion The suppression of over-expression of VEGF in human RPE may down-regulate the expression of eotaxins,via the suppression of NF-κB.
What problem does this paper attempt to address?